Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2010
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255131 Stable hydrophobic topical herbal formulation
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255123 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
10/07/2010US20100255107 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
10/07/2010US20100255097 Polysaccharide derivatives of lipoic acid, and their preparation and use as skin cosmetics and medical devices
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255076 Composition and method for dermal regeneration
10/07/2010US20100255071 Patch and patch preparation
10/07/2010US20100255069 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of angelica sinensis, and methods of preparation thereof
10/07/2010US20100255052 Integrated implant system (iis) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
10/07/2010US20100255045 Composition for photodynamic skin treatment
10/07/2010US20100255024 Composition for inhibition of transplant rejection containing the phellinus linteus mycellia extract as an active ingredient
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254984 Fusion constructs containing active sections of tnf ligands
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254968 Pharmaceutical preparation for treating benign prostatic hyperplasia
10/07/2010US20100254955 Surgical device for skin therapy or testing
10/07/2010US20100254948 Process for the preparation of gamma-amino butyric acid (gaba) by the use of lactic acid bacteria (lab) on agro-and food-industry surplus
10/07/2010US20100254946 Maintenance of hair growth and treatment of hair-loss
10/07/2010US20100254923 Composition and process for protecting cellular targets from aging and photodamage
10/07/2010US20100254919 Topical Turmeric Skin Care Products
10/07/2010US20100254917 Organic nano-particles and process for their preparation
10/07/2010DE102009015002A1 Topical application form, useful for treating e.g. pruritus, burnt skin, dry skin, comprises a carrier material, which is applied with a hydrocolloid matrix and the matrix comprises two hydrocolloids or hydro-gels and one excipient
10/07/2010CA2759201A1 A method of regulating proliferation and differentiation of keratinocyes
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/06/2010EP2236161A1 Polymer conjugates of opioid antagonists
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236150A1 Method for increasing the therapeutic efficacy of curcuminoids and analogues
10/06/2010EP2236144A1 External preparation for preventive or therapeutic use
10/06/2010EP2236129A2 Liposomal ALA Pharmaceutical and Cosmeceutical Compositions and Methods of Treatment
10/06/2010EP2236126A1 Hair and/or Scalp Care Compositions Incorporating Isophaseollin
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2131862B1 Fuid photosensitizer for therapeutic photodynamic skin treatment and its use in non therapeutic photodynamic skin treatments
10/06/2010EP1637132B1 External preparation for athlete´s foot treatment
10/06/2010EP1565158B1 Oxazolidinones for pharmaceutical use in skin pathologies, autoimmune disorders, photoimmunosuppression and graft rejection
10/06/2010EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
10/06/2010CN1899438B Miao medicine powder for curing eczema and rubella
10/06/2010CN1784215B Melanogenesis promoter and melanogenesis promoter composition
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1663559B Skin normalizing agents
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN101854952A Isoflavone formulation
10/06/2010CN101854943A Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
10/06/2010CN101854940A Use of metal astringents for the treatment and prevention of hairy heel warts
10/06/2010CN101854928A Avenanthramide-containing compositions
10/06/2010CN101854925A Use of a monoterpene to increase tissue repair
10/06/2010CN101854911A Composition for external use
10/06/2010CN101854909A Skin-whitening agent containing platycodin D
10/06/2010CN101854905A Composition for external application to skin
10/06/2010CN101851620A Method for producing FGFs by utilizing edible medicinal fungus
10/06/2010CN101851237A spiro compounds, method for preparing same and application thereof
10/06/2010CN101851234A Pyrrolequinoline quinone lithium salt derivative and preparation method thereof
10/06/2010CN101850118A Preparation method and application in preparation of photodynamic therapy medicines of fat-soluble photosensitizer loaded on inorganic salt carrier
10/06/2010CN101850108A Methods and pharmaceutical compositions for healing wounds
10/06/2010CN101850093A Medicinal composition for treating hyperplasia of mammary glands
10/06/2010CN101850092A Medicament for treating trauma and preparation method thereof
10/06/2010CN101850069A Oral Chinese patent medicament capsule for treating white hair of teenagers
10/06/2010CN101850049A Chinese medicament for treating diabetic foot
10/06/2010CN101850048A Chinese medicinal composition and application thereof
10/06/2010CN101850047A Chinese medicinal composition for treating eczema and preparation thereof
10/06/2010CN101850041A Foot bath effervescent tablet for improving tinea pedis and dermatitis
10/06/2010CN101850000A Chinese and western medicinal composition for treating empyrosis
10/06/2010CN101849983A Medicament for treating eczema
10/06/2010CN101849982A Ointment for treating frostbite rhagadia
10/06/2010CN101849977A Method for extracting polyphenol from Mongolian oak leaves
10/06/2010CN101849976A Chinese fir wood and gypsum formula for eliminating dampness and expelling toxin
10/06/2010CN101849948A Cefuroxime axetil composite medicine
10/06/2010CN101849929A Medicine composition for treating psoriasis
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849910A Preparation method of betamethasone dipropionate micro-particle
10/06/2010CN101849902A Preparation method of solid pharmaceutical composition containing desloratadine
10/06/2010CN101849899A Chinese medicinal compound extract and cosmetics comprising same as active ingredient
10/06/2010CN101342269B Chinese traditional medicine preparation for vitligo
10/06/2010CN101310748B Ointment for treating empyrosis
10/06/2010CN101301393B Externally used Chinese medicine preparation for treating skin of head
10/06/2010CN101301354B Externally used medicinal liquor for treating psoriasis
10/06/2010CN101264194B Chinese medicinal composition for treating traumatism
10/06/2010CN101264099B Medicaments for treating acne rosacea, comedo and acne
10/06/2010CN101204431B Preparation method of Chinese traditional medicine capsule for acne and splash
10/06/2010CN101143171B Traditional Chinese medicine and its preparation method and its application
10/06/2010CN101095670B Luteolin phospholipid complexes and method for preparing the same and application thereof
10/06/2010CN101095667B Liquid for disinfecting wound
10/06/2010CN101057942B External applied medicine ointment for treating diabetes foot and its preparing method
10/06/2010CN101049494B Composition of medicine for treating alopecia and preparation method
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807656 Pharmaceutical applications of hyaluronic acid preparations
10/05/2010US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
10/05/2010US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors